ALGS starts phase-1 of ALG-000184 in HBV: https://www.globenewswire.com/news-release/2020/10/30/2117727/0/en/Aligos-Therapeutics-Doses-First-Subject-in-Phase-1-Proof-of-Concept-Study-of-Small-Molecule-Drug-Candidate-ALG-000184-for-Chronic-Hepatitis-B.html ALG-000184 is a CpAM, the same drug class as ENTA’s EDP-514 (#msg-156787041).